Literature DB >> 20875397

A functional interaction between CPI-17 and RACK1 proteins in bronchial smooth muscle cells.

Yoshihiko Chiba1, Miki Tanabe, Hiroyasu Sakai, Shioko Kimura, Miwa Misawa.   

Abstract

CPI-17 is a phosphorylation-dependent inhibitor of smooth muscle myosin light chain. Using yeast two-hybrid system, we have identified the receptor for activated C kinase 1 (RACK1) as a novel interaction partner of CPI-17. The direct interaction and co-localization of CPI-17 with RACK1 were confirmed by immunoprecipitation and confocal microscopy analysis, respectively. An in vitro assay system using recombinant/purified proteins revealed that the PKC-mediated phosphorylation of CPI-17 was augmented in the presence of RACK1. These results suggest that RACK1 may play a role in PKC/CPI-17 signaling pathway.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875397      PMCID: PMC3486735          DOI: 10.1016/j.bbrc.2010.09.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.

Authors:  T P Woodsome; M Eto; A Everett; D L Brautigan; T Kitazawa
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

2.  Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.

Authors:  Masumi Eto; Roland Bock; David L Brautigan; David J Linden
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

3.  A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization.

Authors:  M Eto; T Ohmori; M Suzuki; K Furuya; F Morita
Journal:  J Biochem       Date:  1995-12       Impact factor: 3.387

Review 4.  The role of RhoA-mediated Ca2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness.

Authors:  Yoshihiko Chiba; Miwa Misawa
Journal:  J Smooth Muscle Res       Date:  2004-10

5.  Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle.

Authors:  M Eto; S Senba; F Morita; M Yazawa
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

6.  Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle.

Authors:  L Li; M Eto; M R Lee; F Morita; M Yazawa; T Kitazawa
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

7.  RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway.

Authors:  Xi-Xi Cao; Jing-Da Xu; Jia-Wen Xu; Xiao-Li Liu; Yuan-Yuan Cheng; Qing-Quan Li; Zu-De Xu; Xiu-Ping Liu
Journal:  Breast Cancer Res Treat       Date:  2010-05-25       Impact factor: 4.872

8.  Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle.

Authors:  T Kitazawa; N Takizawa; M Ikebe; M Eto
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

9.  Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins.

Authors:  D Ron; C H Chen; J Caldwell; L Jamieson; E Orr; D Mochly-Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Association of CPI-17 with protein kinase C and casein kinase I.

Authors:  Eva Zemlickova; Franz-Josef Johannes; Alastair Aitken; Thierry Dubois
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

View more
  1 in total

1.  RACK1 is involved in endothelial barrier regulation via its two novel interacting partners.

Authors:  Anita Boratkó; Pál Gergely; Csilla Csortos
Journal:  Cell Commun Signal       Date:  2013-01-11       Impact factor: 5.712

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.